Children's hospital association consensus statements for comorbidities of childhood obesity

Elizabeth Estrada, Ihuoma Eneli, Sarah Hampl, Michele Mietus-Snyder, Nazrat Mirza, Erinn Rhodes, Brooke Sweeney, Lydia Tinajero-Deck, Susan J. Woolford, Stephen J. Pont

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. Methods: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. Results: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. Conclusions: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.

Original languageEnglish (US)
Pages (from-to)304-317
Number of pages14
JournalChildhood Obesity
Volume10
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Pediatric Obesity
Comorbidity
Polycystic Ovary Syndrome
Pediatrics
Obesity
Sleep Apnea Syndromes
Fatty Liver
Therapeutics
Child Care
Dyslipidemias
Liver Diseases
Primary Health Care
Referral and Consultation
Blood Pressure
Hypertension
Lipids
Liver
Enzymes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Pediatrics, Perinatology, and Child Health

Cite this

Estrada, E., Eneli, I., Hampl, S., Mietus-Snyder, M., Mirza, N., Rhodes, E., ... Pont, S. J. (2014). Children's hospital association consensus statements for comorbidities of childhood obesity. Childhood Obesity, 10(4), 304-317. https://doi.org/10.1089/chi.2013.0120

Children's hospital association consensus statements for comorbidities of childhood obesity. / Estrada, Elizabeth; Eneli, Ihuoma; Hampl, Sarah; Mietus-Snyder, Michele; Mirza, Nazrat; Rhodes, Erinn; Sweeney, Brooke; Tinajero-Deck, Lydia; Woolford, Susan J.; Pont, Stephen J.

In: Childhood Obesity, Vol. 10, No. 4, 2014, p. 304-317.

Research output: Contribution to journalArticle

Estrada, E, Eneli, I, Hampl, S, Mietus-Snyder, M, Mirza, N, Rhodes, E, Sweeney, B, Tinajero-Deck, L, Woolford, SJ & Pont, SJ 2014, 'Children's hospital association consensus statements for comorbidities of childhood obesity', Childhood Obesity, vol. 10, no. 4, pp. 304-317. https://doi.org/10.1089/chi.2013.0120
Estrada, Elizabeth ; Eneli, Ihuoma ; Hampl, Sarah ; Mietus-Snyder, Michele ; Mirza, Nazrat ; Rhodes, Erinn ; Sweeney, Brooke ; Tinajero-Deck, Lydia ; Woolford, Susan J. ; Pont, Stephen J. / Children's hospital association consensus statements for comorbidities of childhood obesity. In: Childhood Obesity. 2014 ; Vol. 10, No. 4. pp. 304-317.
@article{8b070405d69a4cb79093a2c780e4bece,
title = "Children's hospital association consensus statements for comorbidities of childhood obesity",
abstract = "Background: Childhood obesity and overweight affect approximately 30{\%} of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. Methods: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. Results: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. Conclusions: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.",
author = "Elizabeth Estrada and Ihuoma Eneli and Sarah Hampl and Michele Mietus-Snyder and Nazrat Mirza and Erinn Rhodes and Brooke Sweeney and Lydia Tinajero-Deck and Woolford, {Susan J.} and Pont, {Stephen J.}",
year = "2014",
doi = "10.1089/chi.2013.0120",
language = "English (US)",
volume = "10",
pages = "304--317",
journal = "Childhood Obesity",
issn = "2153-2168",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Children's hospital association consensus statements for comorbidities of childhood obesity

AU - Estrada, Elizabeth

AU - Eneli, Ihuoma

AU - Hampl, Sarah

AU - Mietus-Snyder, Michele

AU - Mirza, Nazrat

AU - Rhodes, Erinn

AU - Sweeney, Brooke

AU - Tinajero-Deck, Lydia

AU - Woolford, Susan J.

AU - Pont, Stephen J.

PY - 2014

Y1 - 2014

N2 - Background: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. Methods: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. Results: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. Conclusions: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.

AB - Background: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. Methods: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. Results: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. Conclusions: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.

UR - http://www.scopus.com/inward/record.url?scp=84905497972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905497972&partnerID=8YFLogxK

U2 - 10.1089/chi.2013.0120

DO - 10.1089/chi.2013.0120

M3 - Article

C2 - 25019404

AN - SCOPUS:84905497972

VL - 10

SP - 304

EP - 317

JO - Childhood Obesity

JF - Childhood Obesity

SN - 2153-2168

IS - 4

ER -